Asia Pacific Medical Gases Market
Market Size in USD Billion
CAGR :
% 
USD
1.44 Billion
USD
2.80 Billion
2024
2032
 Forecast Period |
2025 –2032 |
 Market Size (Base Year) |
USD 1.44 Billion |
 Market Size (Forecast Year) |
USD 2.80 Billion |
 CAGR |
% |
| Major Markets Players |
|
Asia-Pacific Medical Gas Market Segmentation, By Product (Medical Gases and Medical Gas Equipment), Modality (Standalone and Integrated), Form of Delivery (High Pressure Cylinders, Liquid Cylinders, and Bulk Delivery), Application (Therapeutic, Diagnostic, Pharmaceutical Manufacturing and Research, and Others), End User (Hospitals, Home Healthcare, Academic & Research Institutions, Emergency Services, Pharmaceutical & Biotechnology Companies, Diagnostic & Imaging Centers, and Others) - Industry Trends and Forecast to 2032
Medical Gas Market Size
- The Asia-Pacific Medical Gas market size was valued at USD 1.44 billion in 2024 and is expected to reach USD 2.80 billion by 2032, at a CAGR of 8.7% during the forecast period
- This growth is driven by the hike in ageing population, rise in home healthcare facilities, emerging Asia-Pacificization and economy, increase in the cases of COPD.
Medical Gas Market Analysis
- Medical gases such as oxygen, nitrous oxide, medical air, and carbon dioxide are essential in patient care for anesthesia, ventilation, diagnostics, and therapy. These gases are administered through high-pressure cylinders or centralized systems and supported by gas equipment like flowmeters, regulators, vacuum systems, and manifolds.
- The growing burden of chronic diseases, increasing number of surgeries, and rising demand for emergency and home-based care are primary drivers. Rapidly aging populations and high pollution levels in urban centers have further pushed oxygen therapy adoption.
- China is the dominant country in the Asia-Pacific medical gas market due to its vast hospital infrastructure, high patient volumes, and government initiatives supporting medical infrastructure modernization.
- India is expected to register the highest CAGR in the region due to rapid urbanization, increased healthcare investments, and national programs promoting access to oxygen and critical care in tier-2 and tier-3 cities.
- Medical oxygen segment is expected to dominate the Asia-Pacific medical gas market with the largest market share of 53.2% due to its critical application in surgical procedures, respiratory illnesses, and emergency care. Increased investment in PSA oxygen plants and oxygen therapy awareness post-COVID further supports its leadership.
Report Scope and Medical Gas Market Segmentation
|
Attributes |
Medical Gas Key Market Insights |
|
Segments Covered |
By Product: Medical Gases (Oxygen, Nitrous Oxide, Carbon Dioxide, Medical Air, Nitrogen, Others), Medical Gas Equipment (Manifolds, Hose Assemblies, Flowmeters, Vacuum Systems, Regulators, Outlets, Alarm Systems) By Modality: Standalone, and Integrated By Form of Delivery: High Pressure Cylinders, Liquid Cylinders, and Bulk Delivery By Application: Therapeutic, Diagnostic, Pharmaceutical Manufacturing and Research, and Others By End User: Hospitals, Home Healthcare, Academic & Research Institutions, Emergency Services, Pharmaceutical & Biotechnology Companies, Diagnostic & Imaging Centers, and Others |
|
Countries Covered |
Asia-Pacific
|
|
Key Market Players |
|
|
Market Opportunities |
|
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework. |
Medical Gas Market Trends
“Expansion of Immuno-Oncology and Cell-Based Therapies”
A major trend in the Medical Gas market is the expansion of immuno-oncology and cell-based therapies such as CAR-T, which are transforming cancer treatment protocols
Rising investments by biotech companies in immune checkpoint inhibitors and genetically engineered T-cell therapies are driving long-term growth
For example, the growing number of clinical trials in CAR-T cell therapies across North America and Asia-Pacific signifies sustained innovation in personalized cancer treatment
Medical Gas Market Dynamics
Driver
“Rising Surgical Volume and ICU Demand”
- Asia-Pacific accounts for over 45% of the global surgical volume. According to WHO 2023 data, China and Japan together perform more than 45 million surgical procedures annually, increasing the demand for reliable oxygen and anesthesia gas infrastructure.
For instance, a 2023 report from the Japan Medical Association emphasized the role of centralized gas pipeline systems in over 85% of tertiary care hospitals.
Meanwhile, Southeast Asian countries like Vietnam and the Philippines have increased ICU bed capacity by 40% post-pandemic, boosting demand for gas outlets and emergency oxygen cylinders.
Opportunity “Government-Led Medical Infrastructure Projects”
- National programs such as India’s PM-ABHIM (Ayushman Bharat Health Infrastructure Mission), with over USD 3 billion allocated to public hospital upgrades, and China’s 14th Five-Year Plan supporting oxygen supply system modernization across 1,000 hospitals, are creating significant opportunities for equipment manufacturers and gas suppliers.
For example, in 2024, India’s Health Ministry announced the commissioning of 162 PSA oxygen plants under PM-ABHIM, increasing oxygen self-sufficiency in over 20 states.
Restraint/Challenge
“Supply Chain Inefficiencies and Infrastructure Gaps”
During India’s 2021 COVID-19 second wave, several states faced acute oxygen shortages due to a lack of refill hubs and transportation infrastructure. Reports from the Indian Ministry of Health indicated over 500 hospitals experienced supply interruptions.
In 2023, a survey by Indonesia’s National Health Development Agency noted that over 30% of rural health centers still rely on manually handled cylinders without monitoring alarms, increasing risk of therapy delays and safety breaches.
Medical Gas Market Scope
The market is segmented on the basis application, product type, technology, magnification type, end user, and distribution channel.
|
Segmentation |
Sub-Segmentation |
|
By Product |
|
|
By Modality |
|
|
By Form of Delivery |
|
|
By Application |
|
|
By End User |
|
In 2025, the medical oxygen segment is projected to dominate the market with the largest share in product segment
In 2025, the medical oxygen segment is expected to dominate the Asia-Pacific medical gas market with the largest market share of 53.2% due to its critical application in surgical procedures, respiratory illnesses, and emergency care. Increased investment in PSA oxygen plants and oxygen therapy awareness post-COVID further supports its leadership.
The hospital segment is expected to account for the largest share during the forecast period in end user segment
In 2025, the hospital segment is expected to dominate the market with the largest market share of 60.1% owing to high patient footfall, surgical volume, and emergency care reliance. Government-backed infrastructure investments and smart hospital integrations further consolidate hospital leadership.
Medical Gas Market Regional Analysis
“China Holds the Largest Share in the Asia-Pacific Medical Gas Market”
- China dominates the Asia-Pacific medical gas market owing to its extensive public hospital network, high surgical demand, and large population base.
- Strong manufacturing base and favorable government investments into health infrastructure further contribute to its leadership.
“India is Projected to Register the Highest CAGR in the Asia-Pacific Medical Gas Market”
- India is expected to register the fastest growth due to its increasing healthcare accessibility initiatives, robust demand for medical oxygen, and surge in tertiary care center expansions
- Emergency response programs and subsidies for gas generation systems are boosting market presence in semi-urban and rural zones
Medical Gas Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
The Major Market Leaders Operating in the Market Are:
- Air Liquide (France)
- Linde plc (Ireland)
- Praxair Technology Inc. (U.S.)
- Messer Group GmbH (Germany)
- SOL Group (Italy)
- Atlas Copco AB (Sweden)
- GCE Group AB (Sweden)
- Taiyo Nippon Sanso Corporation (Japan)
- Air Water Inc. (Japan)
Latest Developments in Asia-Pacific Medical Gas Market
- In March 2024, Linde India announced a $60 million investment in new medical oxygen and nitrogen plants across Maharashtra and Gujarat
- In November 2023, Air Liquide expanded its bulk medical gas delivery system network to over 150 hospitals in Southeast Asia
- In July 2023, Taiyo Nippon Sanso Corporation introduced a next-gen oxygen flow monitoring system for smart hospitals in Japan
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
